Olatec Therapeutics, Inc., a leader in the developing class of selective NLRP3 inhibitors, today announced that long-time ...
Santa Barbara, CA (January 27, 2025) — Sansum Diabetes Research Institute (SDRI) proudly announces that Dr. Francine Kaufman, ...
Dr. Mark Corriere, MD works in Columbia, MD as a Diabetes & Metabolism Endocrinologist. Dr. Corriere is board certified in Diabetes, Metabolism & Endocrinology. Dr. Corriere has has worked on more ...